We are live on ! Find out more
CGIM

Cannon Global Investment Management Portfolio holdings

AUM $51.2M
1-Year Est. Return 49.67%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+49.67%
3 Year Est. Return
+104.84%
5 Year Est. Return
10 Year Est. Return
AUM
$51.2M
AUM Growth
+$11.4M
Cap. Flow
+$12.5M
Cap. Flow %
24.38%
Top 10 Hldgs %
39.01%
Holding
110
New
51
Increased
23
Reduced
7
Closed
28

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$1.92M
2
RNAM
Avidity Biosciences
RNAM
+$1.05M
3
VRT icon
Vertiv
VRT
+$1.04M
4
UNF icon
Unifirst Corp
UNF
+$992K
5
WBD icon
Warner Bros
WBD
+$966K

Sector Composition

Rank Sector Weight
1 Healthcare 22.05%
2 Financials 15.57%
3 Technology 12.55%
4 Industrials 12.22%
5 Communication Services 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNA
51
Atrium Therapeutics
RNA
$208M
$335K 0.66%
+25,087
New +$352K
RDDT icon
52
Reddit
RDDT
$34.9B
$323K 0.63%
2,400
-800
-25% -$136K
BHF icon
53
Brighthouse Financial
BHF
$3.77B
$299K 0.58%
5,000
-10,500
-68% -$655K
BEAG
54
Bold Eagle Acquisition Corp
BEAG
$334M
$299K 0.58%
28,300
+3,300
+13% +$34.9K
ULS icon
55
UL Solutions
ULS
$17.7B
$291K 0.57%
+3,400
New +$268K
SVAC
56
DELISTED
Spring Valley Acquisition Corp III
SVAC
$279K 0.55%
+27,500
New +$287K
MDLN
57
Medline Inc
MDLN
$33.6B
$267K 0.52%
+6,000
New +$265K
HOLX
58
DELISTED
Hologic
HOLX
$265K 0.52%
+3,500
New +$263K
CZR icon
59
Caesars Entertainment
CZR
$6.08B
$264K 0.52%
+10,000
New +$238K
TBPH icon
60
Theravance Biopharma
TBPH
$877M
$260K 0.51%
+16,047
New +$284K
PAY icon
61
Paymentus
PAY
$3.75B
$257K 0.5%
+10,100
New +$266K
BCRX icon
62
BioCryst Pharmaceuticals
BCRX
$2.36B
$253K 0.49%
+26,600
New +$207K
DMRA
63
Damora Therapeutics
DMRA
$1.94B
$241K 0.47%
+9,300
New +$239K
GDEN
64
DELISTED
Golden Entertainment
GDEN
$235K 0.46%
+8,800
New +$244K
BF.B icon
65
Brown-Forman Class B
BF.B
$11.7B
$233K 0.45%
+8,800
New +$236K
GME.WS
66
GameStop Corp Warrants
GME.WS
$222K 0.43%
57,400
+21,500
+60% +$84.1K
IVVD icon
67
Invivyd
IVVD
$219M
$209K 0.41%
+161,000
New +$296K
VOR icon
68
Vor Biopharma
VOR
$980M
$209K 0.41%
+11,700
New +$165K
QURE icon
69
uniQure
QURE
$2.77B
$199K 0.39%
+12,200
New +$247K
DAAQ
70
Digital Asset Acquisition Corp
DAAQ
$239M
$199K 0.39%
19,400
+2,900
+18% +$29.6K
CBIO
71
Crescent Biopharma
CBIO
$526M
$187K 0.37%
+10,200
New +$117K
GPAT
72
GP-Act III Acquisition Corp
GPAT
$396M
$181K 0.35%
16,700
+2,200
+15% +$23.7K
CTNM
73
Contineum Therapeutics
CTNM
$532M
$170K 0.33%
+13,000
New +$174K
LPBB
74
Launch Two Acquisition Corp
LPBB
$309M
$134K 0.26%
12,600
+1,600
+15% +$16.9K
OCGN icon
75
Ocugen
OCGN
$460M
$127K 0.25%
+70,000
New +$121K

Similar funds

Cannon Global Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, Cannon Global Investment Management held 110 positions worth $51.2M, up 29% from $39.8M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Cannon Global Investment Management deployed $12.5M of net new capital in Q1 2026, opening 51 new positions and adding to 23 existing holdings. Its largest new stake was Qiagen: 34,400 shares worth $1.38M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 9.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Unifirst Corp, an estimated $992K trimmed.

  • Cannon Global Investment Management's largest Q1 2026 buy was Qiagen: 34,400 shares worth $1.38M.
  • Cannon Global Investment Management added most to Electronic Arts in Q1 2026, an estimated $989K increase.
  • Cannon Global Investment Management's biggest Q1 2026 reduction was Unifirst Corp, cutting an estimated $992K.
  • Cannon Global Investment Management fully exited Walmart Inc in Q1 2026, selling an estimated $1.92M.
  • Cannon Global Investment Management's ten largest holdings make up 39% of its $51.2M portfolio in Q1 2026.
  • Cannon Global Investment Management opened 51 new positions and closed 28 in Q1 2026.
  • Cannon Global Investment Management's portfolio value rose 29% quarter-over-quarter to $51.2M.

Based on Cannon Global Investment Management's 13F filing for Q1 2026, filed 21 Apr 2026.